Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Molecular Profiling and Disease Tracking of Post-Transplant Lymphoproliferative Diseases Using Cell-Free DNA

Nick Veltmaat, Yujie Zhong, Filipe Montes De Jesus, Johanna Bult, Pim Mutsaers, Wendy B.C. Stevens, Rogier Mous, Marjolein W.M. van der Poel, Martine E.D. Chamuleau, Walter Noordzij, Erik A.M. Verschuuren, Joost L. Kluiver, Arjan Diepstra, Wouter Plattel, Anke van den Berg, Marcel Nijland

Blood (2024) 144 (Supplement 1): 6234.

https://doi.org/10.1182/blood-2024-210000

Published: 2024

Journal Articles

Whole Body CD8 + T Cell PET Imaging in Patients with DLBCL before and during Anti-CD19 CAR T Cell Therapy

Jaap A. van Doesum, Kylie Keijzer, Janneke W. de Boer, Nienke A.M. Smit, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge, Frank R. Pierik, Gerwin A. Huls, Lisanne V. van Dijk, Lydia Visser, Arjan Diepstra, Walter Noordzij, Simon P. Williams, Alexander Ungewickell, Sjoerd G. Elias, Elisabeth G.E. de Vries, Anne G.H. Niezink, Tom van Meerten

Blood (2024) 144 (Supplement 1): 1037.

https://doi.org/10.1182/blood-2024-199474

Published: 2024

Journal Articles

Unveiling Transformation Mechanisms of Nodal Marginal Zone Lymphoma Using a Multi-Omics Approach

Johanna A.A. Bult, Yujie Zhong, Fleur A. De Groot, Ruben A.L. De Groen, Nick Veltmaat, Diana Al-Sarayfi, Wouter Plattel, Joost L. Kluiver, Anke Van Den Berg, Stefano Rosati, Arjan Diepstra, Joost S.P. Vermaat, Marcel Nijland

Blood (2024) 144 (Supplement 1): 2984.

https://doi.org/10.1182/blood-2024-206997

Published: 2024

Journal Articles

Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume during Anti-PD1-Based First-Line HL Treatment in the GHSG Phase II Nivahl Trial

Paul J. Bröckelmann, Sophie Teesink, Lydia Visser, Conrad-Amadeus Voltin, Helen Kaul, Hans Schlösser, Bart-Jan Kroesen, Carsten Kobe, Peter Borchmann, Arjan Diepstra, Wouter Plattel

Blood (2024) 144 (Supplement 1): 3044.

https://doi.org/10.1182/blood-2024-201547

Published: 2024

Journal Articles

Dynamics of Circulating Tumor DNA in Relapsed/Refractory DLBCL Patients

Yujie Zhong, Johanna Bult, Nick Veltmaat, Filipe Montes de Jesus, Diana Al-Sarayfi, Anke Van Den Berg, Joost L. Kluiver, Wouter Plattel, Arjan Diepstra, Marcel Nijland

Blood (2024) 144 (Supplement 1): 6198.

https://doi.org/10.1182/blood-2024-203072

Published: 2024

Journal Articles

Elevated serum TARC levels precede classic Hodgkin lymphoma diagnosis by several years

Arjan Diepstra, Ilja M. Nolte, Anke van den Berg, Larry I. Magpantay, Otoniel Martínez-Maza, Lynn I. Levin

Blood (2023) 142 (22): 1928–1931.

https://doi.org/10.1182/blood.2023020959

Published: 2023

Includes: Supplemental data

Journal Articles

Genomic Landscaping of Post-Transplant Lymphoproliferative Disorders Using Circulating Tumor DNA

Nick Veltmaat, Geok Wee Tan, Johanna A.A. Bult, Yujie Zhong, Wouter J. Plattel, Rogier Mous, Pim Mutsaers, Wendy B.C. Stevens, Joost S.P. Vermaat, Martine E.D. Chamuleau, Arjan Diepstra, Anke Van Den Berg, Filipe Montes De Jesus, Marcel Nijland

Blood (2022) 140 (Supplement 1): 9274–9276.

https://doi.org/10.1182/blood-2022-171213

Published: 2022

Journal Articles

Tumor Microenvironment Composition Correlates with Quantitative 18F-FDG PET-CT Features and Serum TARC in Patients with Relapsed or Refractory Hodgkin Lymphoma

Julia Driessen, Wouter J. Plattel, Lydia Visser, Anke Van Den Berg, Josée M. Zijlstra, Sanne Tonino, Gerben JC Zwezerijnen, Ronald Boellaard, Marie José Kersten, Arjan Diepstra

Blood (2022) 140 (Supplement 1): 9213–9215.

https://doi.org/10.1182/blood-2022-166120

Published: 2022

Journal Articles

Outcome of Transformed Marginal Zone Lymphoma: A Population Based Study

Johanna A.A. Bult, Francien Huisman, Yujie Zhong, Nick Veltmaat, Sanne Tonino, Joost S.P. Vermaat, Martine E.D. Chamuleau, Arjan Diepstra, Wouter J. Plattel, Anke Van Den Berg, Mirian Brink, Marcel Nijland

Blood (2022) 140 (Supplement 1): 6514–6516.

https://doi.org/10.1182/blood-2022-166052

Published: 2022

Journal Articles

Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

Blood (2022) 140 (Supplement 1): 3534–3536.

https://doi.org/10.1182/blood-2022-159036

Published: 2022

Journal Articles

Elevated CCL22 and sIL2Rα Levels Precede the Diagnosis of Young Adult Classical Hodgkin Lymphoma: A Nested Case-Control Study from the DoD Serum Repository

Wendy Cozen, Jia Yin Wan, David V Conti, Marta Epeldegui, Yu Guo, Larry Magpantay, Ilja Nolte, Arjan Diepstra, Lynn Levin, Otoniel Martinez-Maza

Blood (2022) 140 (Supplement 1): 3678–3679.

https://doi.org/10.1182/blood-2022-168253

Published: 2022

Journal Articles

Detection of Cell Free Tumor DNA in Plasma of Patients with Large B-Cell Lymphoma of the Sanctuary Sites By Digital Droplet PCR

Yujie Zhong, Geok Tan, Wouter J. Plattel, Johanna A.A. Bult, Nick Veltmaat, Joost L. Kluiver, Roelien Enting, Arjan Diepstra, Anke Van Den Berg, Marcel Nijland

Blood (2022) 140 (Supplement 1): 9516–9517.

https://doi.org/10.1182/blood-2022-166357

Published: 2022

Journal Articles

Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Blood (2022) 140 (Supplement 1): 369–371.

https://doi.org/10.1182/blood-2022-163244

Published: 2022

Journal Articles

Special Anatomical Subtypes of Diffuse Large B-Cell Lymphoma Have Distinct Tumor Microenvironments

Blood (2022) 140 (Supplement 1): 164–165.

https://doi.org/10.1182/blood-2022-156103

Published: 2022

Journal Articles

Molecular Diagnostics for TP53 Is Recommended in B-Cell Lymphomas

Lorraine M. De Haan, Ruben A.L. De Groen, Fleur de Groot, Troy Noordenbos, Tom van Wezel, Ronald van Eijk, Dina Ruano, Arjan Diepstra, Lianne Koens, Aniko Sijs-Szabo, Hendrik Veelken, Arjen Cleven, Patty M. Jansen, Joost S.P. Vermaat

Blood (2022) 140 (Supplement 1): 11916–11918.

https://doi.org/10.1182/blood-2022-163197

Published: 2022

Journal Articles

A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma

Rebecca L. Johnston, Anja Mottok, Fong Chun Chan, Aixiang Jiang, Arjan Diepstra, Lydia Visser, Adèle Telenius, Randy D. Gascoyne, Debra L. Friedman, Cindy L. Schwartz, Kara M. Kelly, David W. Scott, Terzah M. Horton, Christian Steidl

Blood (2022) 139 (6): 889–893.

https://doi.org/10.1182/blood.2021011941

Published: 2022

Includes: Supplemental data

Journal Articles

Low Mutational Burden of Extra Nodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome

Johanna A.A. Bult, Jessica R. Plaça, Erlin A. Haacke, Gwenny M. Verstappen, Frederik K.L. Spijkervet, Frans G.M. Kroese, Wouter J. Plattel, Joost S.P. Vermaat, Hendrika Bootsma, Bert Van der Vegt, Arjan Diepstra, Anke Van Den Berg, Klaas Kok, Marcel Nijland

Blood (2021) 138 (Supplement 1): 1331.

https://doi.org/10.1182/blood-2021-153130

Published: 2021

Journal Articles

Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58

Johanna Veldman, Lydia Visser, Magdalena Huberts-Kregel, Natasja Muller, Bouke Hepkema, Anke van den Berg, Arjan Diepstra

Blood (2020) 136 (21): 2437–2441.

https://doi.org/10.1182/blood.2020005546

Published: 2020

Includes: Supplemental data

Journal Articles

High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype

Blood (2019) 134 (Supplement_1): 1484.

https://doi.org/10.1182/blood-2019-129832

Published: 2019

Journal Articles

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

Francesco d'Amore, MD, Sirpa Leppä, MD, Maria Gomes da Silva, MD PhD, Thomas Relander, Grete Fossum Lauritzsen, Peter De Nully Brown, Antonio Pezzutto, Jeanette K. Doorduijn, MD PhD, Eckhart Weidmann, Michel van Gelder, Achiel Van Hoof, Ilse Christiansen, Unn Merete Fagerli, MD PhD, Hans Hagberg, MD, P.J. Lugtenburg, Jan Walewski, Ka Lung Wu, Hilde Maria Demuynck, Rob Fijnheer, Jacob H. Christensen, Milada Jankovská, MD, Pär L. Josefsson, Hanneke Kluin-Nelemans, Jose Mario Mariz, MD, Mats A. Merup, Thomas Noesslinger, Eric Van Den Neste, Josée M Zijlstra, MD, Georg Hopfinger, MD, VIT Prochazka, MD, Esa Jantunen, MD PhD, Ludmila Boudova, Jose Cabecadas, Andreas Chott, Jan M.A. Delabie, MD PhD, Laurence de Leval, MD, Arjan Diepstra, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Peter Noergaard, Andreas Rosenwald, Grzegorz Rymkiewicz, Christer Sundström, Lorenz Truemper, MD, Gerald Wulf, MD, Lauren Chong, MSc, Alyssa Bouska, PhD, Lynette Smith, Christian Gisselbrecht, Marita Ziepert, PhD, Markus Loeffler, MD, Knut Liestol, Christian Steidl, MD, Randy D. Gascoyne, MD, David W. Scott, PhDMD,FRACP,FRCPA, Bettina Altmann, PhD, Javeed Iqbal, §, Wing C Chan, MD, Helle Toldbod, MS,PhD

Blood (2018) 132 (Supplement 1): 998.

https://doi.org/10.1182/blood-2018-99-110429

Published: 2018

NARROW

Molecular Profiling and Disease Tracking of Post-Transplant Lymphoproliferative Diseases Using Cell-Free DNA

Whole Body CD8 + T Cell PET Imaging in Patients with DLBCL before and during Anti-CD19 CAR T Cell Therapy

Unveiling Transformation Mechanisms of Nodal Marginal Zone Lymphoma Using a Multi-Omics Approach

Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume during Anti-PD1-Based First-Line HL Treatment in the GHSG Phase II Nivahl Trial

Dynamics of Circulating Tumor DNA in Relapsed/Refractory DLBCL Patients

Elevated serum TARC levels precede classic Hodgkin lymphoma diagnosis by several years

Genomic Landscaping of Post-Transplant Lymphoproliferative Disorders Using Circulating Tumor DNA

Tumor Microenvironment Composition Correlates with Quantitative 18F-FDG PET-CT Features and Serum TARC in Patients with Relapsed or Refractory Hodgkin Lymphoma

Outcome of Transformed Marginal Zone Lymphoma: A Population Based Study

Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

Elevated CCL22 and sIL2Rα Levels Precede the Diagnosis of Young Adult Classical Hodgkin Lymphoma: A Nested Case-Control Study from the DoD Serum Repository

Detection of Cell Free Tumor DNA in Plasma of Patients with Large B-Cell Lymphoma of the Sanctuary Sites By Digital Droplet PCR

Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Special Anatomical Subtypes of Diffuse Large B-Cell Lymphoma Have Distinct Tumor Microenvironments

Molecular Diagnostics for TP53 Is Recommended in B-Cell Lymphomas

A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma

Low Mutational Burden of Extra Nodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome

Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58

High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only